Laryngeal cancer with lung metastases showing long-term complete response and delayed immune-related adverse event after nivolumab discontinuation
T Kondo, M Nakatsugawa, M Okubo… - Ear, Nose & Throat …, 2021 - journals.sagepub.com
We report a case of laryngeal cancer with multiple lung metastases that maintained a
complete response (CR) for 18 months after discontinuing nivolumab treatment, with colitis …
complete response (CR) for 18 months after discontinuing nivolumab treatment, with colitis …